Immunological memory diversity in the human upper airway.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
31 Jul 2024
Historique:
received: 06 12 2023
accepted: 24 06 2024
medline: 1 8 2024
pubmed: 1 8 2024
entrez: 31 7 2024
Statut: aheadofprint

Résumé

The upper airway is an important site of infection, but immune memory in the human upper airway is poorly understood, with implications for COVID-19 and many other human diseases

Identifiants

pubmed: 39085605
doi: 10.1038/s41586-024-07748-8
pii: 10.1038/s41586-024-07748-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s), under exclusive licence to Springer Nature Limited.

Références

Sette, A. & Crotty, S. Immunological memory to SARS‐CoV‐2 infection and COVID‐19 vaccines. Immunol. Rev. 310, 27–46 (2022).
pubmed: 35733376 doi: 10.1111/imr.13089
Allie, S. R. & Randall, T. D. Resident memory B cells. Viral Immunol. 33, 282–293 (2020).
pubmed: 32023188 pmcid: 7247033 doi: 10.1089/vim.2019.0141
Topol, E. J. & Iwasaki, A. Operation nasal vaccine-lightning speed to counter COVID-19. Sci. Immunol. 7, eadd9947 (2022).
pubmed: 35862488 doi: 10.1126/sciimmunol.add9947
Zheng, M. Z. M. & Wakim, L. M. Tissue resident memory T cells in the respiratory tract. Mucosal Immunol. 15, 379–388 (2022).
pubmed: 34671115 doi: 10.1038/s41385-021-00461-z
Poon, M. M. L. et al. Tissue adaptation and clonal segregation of human memory T cells in barrier sites. Nat. Immunol. 24, 309–319 (2023).
pubmed: 36658238 pmcid: 10063339 doi: 10.1038/s41590-022-01395-9
Domínguez Conde, C. et al. Cross-tissue immune cell analysis reveals tissue-specific features in humans. Science 376, eabl5197 (2022).
pubmed: 35549406 pmcid: 7612735 doi: 10.1126/science.abl5197
Clark, R. A. Resident memory T cells in human health and disease. Sci. Transl. Med. 7, 269rv1 (2015).
pubmed: 25568072 pmcid: 4425129 doi: 10.1126/scitranslmed.3010641
Lange, J., Rivera-Ballesteros, O. & Buggert, M. Human mucosal tissue-resident memory T cells in health and disease. Mucosal Immunol. 15, 389–397 (2022).
pubmed: 34743182 doi: 10.1038/s41385-021-00467-7
Thome, J. J. C. et al. Spatial map of human T cell compartmentalization and maintenance over decades of life. Cell 159, 814–828 (2014).
pubmed: 25417158 pmcid: 4243051 doi: 10.1016/j.cell.2014.10.026
Gray, J. I. & Farber, D. L. Tissue-resident immune cells in humans. Annu. Rev. Immunol. 40, 195–220 (2022).
pubmed: 35044795 pmcid: 11194112 doi: 10.1146/annurev-immunol-093019-112809
Masopust, D. & Soerens, A. G. Tissue-resident T cells and other resident leukocytes. Annu. Rev. Immunol. 37, 521–546 (2019).
pubmed: 30726153 pmcid: 7175802 doi: 10.1146/annurev-immunol-042617-053214
Snyder, M. E. et al. Generation and persistence of human tissue-resident memory T cells in lung transplantation. Sci. Immunol. 4, eaav5581 (2019).
pubmed: 30850393 pmcid: 6435356 doi: 10.1126/sciimmunol.aav5581
Weisel, N. M. et al. Comprehensive analyses of B-cell compartments across the human body reveal novel subsets and a gut-resident memory phenotype. Blood 136, 2774–2785 (2020).
pubmed: 32750113 pmcid: 7731793 doi: 10.1182/blood.2019002782
Havenar-Daughton, C., Lee, J. H. & Crotty, S. Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem. Immunol. Rev. 275, 49–61 (2017).
pubmed: 28133798 doi: 10.1111/imr.12512
Havenar-Daughton, C. et al. Normal human lymph node T follicular helper cells and germinal center B cells accessed via fine needle aspirations. J. Immunol. Methods 479, 112746 (2020).
pubmed: 31958451 pmcid: 7200018 doi: 10.1016/j.jim.2020.112746
Alsoussi, W. B. et al. SARS-CoV-2 Omicron boosting induces de novo B cell response in humans. Nature 617, 592–598 (2023).
pubmed: 37011668 doi: 10.1038/s41586-023-06025-4
Leggat, D. J. et al. Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science 378, eadd6502 (2022).
pubmed: 36454825 pmcid: 11103259 doi: 10.1126/science.add6502
Victora, G. D. & Nussenzweig, M. C. Germinal Centers. Annu. Rev. Immunol. 40, 413–442 (2022).
pubmed: 35113731 doi: 10.1146/annurev-immunol-120419-022408
Xu, Q. et al. Adaptive immune responses to SARS-CoV-2 persist in the pharyngeal lymphoid tissue of children. Nat. Immunol. 24, 186–199 (2023).
pubmed: 36536106 doi: 10.1038/s41590-022-01367-z
Kumar, B. V. et al. Human tissue-resident memory T cells are defined by core transcriptional and functional signatures in lymphoid and mucosal sites. Cell Rep. 20, 2921–2934 (2017).
pubmed: 28930685 pmcid: 5646692 doi: 10.1016/j.celrep.2017.08.078
Kusnadi, A. et al. Severely ill COVID-19 patients display impaired exhaustion features in SARS-CoV-2-reactive CD8
pubmed: 33478949 pmcid: 8101257 doi: 10.1126/sciimmunol.abe4782
Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4
pubmed: 33096020 pmcid: 7534589 doi: 10.1016/j.cell.2020.10.001
Schmiedel, B. J. et al. Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type-dependent effects of disease-risk variants. Sci. Immunol. 7, eabm2508 (2022).
pubmed: 35213211 pmcid: 9035271 doi: 10.1126/sciimmunol.abm2508
FitzPatrick, M. E. B. et al. Human intestinal tissue-resident memory T cells comprise transcriptionally and functionally distinct subsets. Cell Reports 34, 108661 (2021).
pubmed: 33472060 doi: 10.1016/j.celrep.2020.108661
Crotty, S. T follicular helper cell biology: a decade of discovery and diseases. Immunity 50, 1132–1148 (2019).
pubmed: 31117010 pmcid: 6532429 doi: 10.1016/j.immuni.2019.04.011
Mudd, P. A. et al. SARS-CoV-2 mRNA vaccination elicits a robust and persistent T follicular helper cell response in humans. Cell 185, 603–613.e15 (2022).
pubmed: 35026152 doi: 10.1016/j.cell.2021.12.026
Nolan, S. et al. A large-scale database of T-cell receptor beta (TCRb) sequences and binding associations from natural and synthetic exposure to SARS-CoV-2. Preprint at Research Square https://doi.org/10.21203/rs.3.rs-51964/v1 (2020).
Goncharov, M. et al. VDJdb in the pandemic era: a compendium of T cell receptors specific for SARS-CoV-2. Nat. Methods 19, 1017–1019 (2022).
pubmed: 35970936 doi: 10.1038/s41592-022-01578-0
Rowntree, L. C. et al. SARS-CoV-2-specific T cell memory with common TCRαβ motifs is established in unvaccinated children who seroconvert after infection. Immunity 55, 1299–1315.e4 (2022).
pubmed: 35750048 pmcid: 9174177 doi: 10.1016/j.immuni.2022.06.003
Pogorelyy, M. V. et al. Resolving SARS-CoV-2 CD4
pubmed: 35841887 pmcid: 9247234 doi: 10.1016/j.xcrm.2022.100697
Tan, H.-X. et al. Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles. Sci. Immunol. 7, eabf5314 (2022).
pubmed: 35089815 doi: 10.1126/sciimmunol.abf5314
Barker, K. A. et al. Lung-resident memory B cells protect against bacterial pneumonia. J. Clin. Invest. 131, e141810 (2021).
pubmed: 34060477 pmcid: 8159694 doi: 10.1172/JCI141810
Gregoire, C. et al. Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism. Immunity 55, 1216–1233.e9 (2022).
pubmed: 35768001 pmcid: 9396418 doi: 10.1016/j.immuni.2022.06.002
Allie, S. R. et al. The establishment of resident memory B cells in the lung requires local antigen encounter. Nat. Immunol. 20, 97–108 (2019).
pubmed: 30510223 doi: 10.1038/s41590-018-0260-6
Ehrhardt, G. R. A. et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J. Exp. Med. 202, 783–791 (2005).
pubmed: 16157685 pmcid: 2212938 doi: 10.1084/jem.20050879
Ehrhardt, G. R. A. et al. Discriminating gene expression profiles of memory B cell subpopulations. J. Exp. Med. 205, 1807–1817 (2008).
pubmed: 18625746 pmcid: 2525601 doi: 10.1084/jem.20072682
King, H. W. et al. Single-cell analysis of human B cell maturation predicts how antibody class switching shapes selection dynamics. Sci. Immunol. 6, eabe6291 (2021).
pubmed: 33579751 doi: 10.1126/sciimmunol.abe6291
Zumaquero, E. et al. IFNγ induces epigenetic programming of human T-bethi B cells and promotes TLR7/8 and IL-21 induced differentiation. eLife 8, e41641 (2019).
pubmed: 31090539 pmcid: 6544433 doi: 10.7554/eLife.41641
Knox, J. J. et al. T-bet
pubmed: 28422752 pmcid: 5396521 doi: 10.1172/jci.insight.92943
Duan, M. et al. Understanding heterogeneity of human bone marrow plasma cell maturation and survival pathways by single-cell analyses. Cell Rep. 42, 112682 (2023).
pubmed: 37355988 pmcid: 10391632 doi: 10.1016/j.celrep.2023.112682
Lim, J. M. E. et al. SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8
pubmed: 35972472 pmcid: 9386509 doi: 10.1084/jem.20220780
Dan, J. M. et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371, eabf4063 (2021).
pubmed: 33408181 doi: 10.1126/science.abf4063
Grifoni, A. et al. Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell 181, 1489–1501.e15 (2020).
pubmed: 32473127 pmcid: 7237901 doi: 10.1016/j.cell.2020.05.015
Dan, J. M. et al. Recurrent group A Streptococcus tonsillitis is an immunosusceptibility disease involving antibody deficiency and aberrant T
pubmed: 30728285 pmcid: 6561727 doi: 10.1126/scitranslmed.aau3776
Ramirez, S. I. et al. Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses. JCI Insight 7, e163471 (2022).
pubmed: 36378539 pmcid: 9869965 doi: 10.1172/jci.insight.163471
Yu, E. D. et al. Development of a T cell-based immunodiagnostic system to effectively distinguish SARS-CoV-2 infection and COVID-19 vaccination status. Cell Host Microbe 30, 388–399.e3 (2022).
pubmed: 35172129 pmcid: 8824221 doi: 10.1016/j.chom.2022.02.003
Grifoni, A. et al. SARS-CoV-2 human T cell epitopes: adaptive immune response against COVID-19. Cell Host Microbe 29, 1076–1092 (2021).
pubmed: 34237248 pmcid: 8139264 doi: 10.1016/j.chom.2021.05.010
Hao, Y. et al. Integrated analysis of multimodal single-cell data. Cell 184, 3573–3587.e29 (2021).
pubmed: 34062119 pmcid: 8238499 doi: 10.1016/j.cell.2021.04.048
Korotkevich, G. et al. Fast gene set enrichment analysis. Preprint at bioRXiv https://doi.org/10.1101/060012 (2016).
Lee, J. H. et al. Long-primed germinal centres with enduring affinity maturation and clonal migration. Nature 609, 998–1004 (2022).
pubmed: 36131022 pmcid: 9491273 doi: 10.1038/s41586-022-05216-9
Holla, P. et al. Shared transcriptional profiles of atypical B cells suggest common drivers of expansion and function in malaria, HIV, and autoimmunity. Sci. Adv. 7, eabg8384 (2021).
pubmed: 34039612 pmcid: 8153733 doi: 10.1126/sciadv.abg8384
Lopes De Assis, F. et al. Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine. Cell Rep. 42, 112780 (2023).
pubmed: 37440409 pmcid: 10529190 doi: 10.1016/j.celrep.2023.112780
Yermanos, A. et al. Platypus: an open-access software for integrating lymphocyte single-cell immune repertoires with transcriptomes. NAR Genom. Bioinform. 3, lqab023 (2021).
pubmed: 33884369 pmcid: 8046018 doi: 10.1093/nargab/lqab023
Gupta, N. T. et al. Change-O: a toolkit for analyzing large-scale B cell immunoglobulin repertoire sequencing data. Bioinformatics 31, 3356–3358 (2015).
pubmed: 26069265 pmcid: 4793929 doi: 10.1093/bioinformatics/btv359
Vander Heiden, J. A. et al. pRESTO: a toolkit for processing high-throughput sequencing raw reads of lymphocyte receptor repertoires. Bioinformatics 30, 1930–1932 (2014).
doi: 10.1093/bioinformatics/btu138
Gupta, N. T. et al. Hierarchical clustering can identify B cell clones with high confidence in Ig repertoire sequencing data. J. Immunol. 198, 2489–2499 (2017).
pubmed: 28179494 doi: 10.4049/jimmunol.1601850
Nouri, N. & Kleinstein, S. H. Somatic hypermutation analysis for improved identification of B cell clonal families from next-generation sequencing data. PLoS Comput. Biol. 16, e1007977 (2020).
pubmed: 32574157 pmcid: 7347241 doi: 10.1371/journal.pcbi.1007977
Ye, J., Ma, N., Madden, T. L. & Ostell, J. M. IgBLAST: an immunoglobulin variable domain sequence analysis tool. Nucleic Acids Res. 41, W34–W40 (2013).
pubmed: 23671333 pmcid: 3692102 doi: 10.1093/nar/gkt382
Giudicelli, V., Chaume, D. & Lefranc, M.-P. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res. 33, D256–D261 (2005).
pubmed: 15608191 doi: 10.1093/nar/gki010
Hoehn, K. B. et al. Repertoire-wide phylogenetic models of B cell molecular evolution reveal evolutionary signatures of aging and vaccination. Proc. Natl Acad. Sci. USA 116, 22664–22672 (2019).
pubmed: 31636219 pmcid: 6842591 doi: 10.1073/pnas.1906020116
Hoehn, K. B. et al. Human B cell lineages associated with germinal centers following influenza vaccination are measurably evolving. eLife 10, e70873 (2021).
pubmed: 34787567 pmcid: 8741214 doi: 10.7554/eLife.70873
Hoehn, K. B., Pybus, O. G. & Kleinstein, S. H. Phylogenetic analysis of migration, differentiation, and class switching in B cells. PLoS Comput. Biol. 18, e1009885 (2022).
pubmed: 35468128 pmcid: 9037912 doi: 10.1371/journal.pcbi.1009885
Raybould, M. I. J., Kovaltsuk, A., Marks, C. & Deane, C. M. CoV-AbDab: the coronavirus antibody database. Bioinformatics 37, 734–735 (2021).
pubmed: 32805021 doi: 10.1093/bioinformatics/btaa739
Kaku, C. I. et al. Evolution of antibody immunity following Omicron BA.1 breakthrough infection. Nat. Commun. 14, 2751 (2023).
pubmed: 37173311 pmcid: 10180619 doi: 10.1038/s41467-023-38345-4
Chen, E. C. et al. Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals. Cell Rep. 36, 109604 (2021).
pubmed: 34411541 pmcid: 8352653 doi: 10.1016/j.celrep.2021.109604
Barnes, C. O. et al. Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies. Cell 182, 828–842.e16 (2020).
pubmed: 32645326 pmcid: 7311918 doi: 10.1016/j.cell.2020.06.025
Tarke, A. et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 185, 847–859.e11 (2022).
pubmed: 35139340 pmcid: 8784649 doi: 10.1016/j.cell.2022.01.015
Hastie, K. M. et al. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep. 42, 112421 (2023).
pubmed: 37083327 pmcid: 10083196 doi: 10.1016/j.celrep.2023.112421
Lee, J. H. et al. A broadly neutralizing antibody targets the dynamic HIV envelope trimer apex via a long, rigidified, and anionic β-hairpin structure. Immunity 46, 690–702 (2017).
pubmed: 28423342 pmcid: 5400778 doi: 10.1016/j.immuni.2017.03.017
Zhang, Z. et al. Humoral and cellular immune memory to four COVID-19 vaccines. Cell 185, 2434–2451.e17 (2022).
pubmed: 35764089 pmcid: 9135677 doi: 10.1016/j.cell.2022.05.022

Auteurs

Sydney I Ramirez (SI)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.

Farhoud Faraji (F)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, CA, USA.

L Benjamin Hills (LB)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Pediatrics, University of California San Diego, La Jolla, CA, USA.

Paul G Lopez (PG)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Benjamin Goodwin (B)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Hannah D Stacey (HD)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Henry J Sutton (HJ)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Kathryn M Hastie (KM)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Erica Ollmann Saphire (EO)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA.

Hyun Jik Kim (HJ)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.
Department of Otorhinolaryngology, College of Medicine, Seoul National University, Seoul, Korea.

Sara Mashoof (S)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Carol H Yan (CH)

Department of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, CA, USA.

Adam S DeConde (AS)

Department of Otolaryngology-Head and Neck Surgery, University of California San Diego, La Jolla, CA, USA.

Gina Levi (G)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA.

Shane Crotty (S)

Center for Vaccine Innovation, La Jolla Institute for Immunology, La Jolla, CA, USA. shane@lji.org.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California San Diego, La Jolla, CA, USA. shane@lji.org.

Classifications MeSH